Metronidazole

Reduced susceptibility to metronidazole was associated with decreased clinical response rates in patients with Clostridioides difficile infection, according to a study published in Open Forum Infectious Diseases.

SAN DIEGO – Non-alcoholic steatohepatitis-related cirrhosis may be an independent risk factor for recurrent Clostridium difficile infections, according to findings presented at Digestive Disease Week.

SAN DIEGO — Orally delivered fecal microbiota transplantation did not help reduce symptoms in patients with diarrhea-predominant irritable bowel syndrome whether or not they were pre-treated with antibiotics, according to data presented at Digestive Disease Week.

In this guest commentary, Dale N. Gerding, MD, professor of medicine at Loyola University Chicago Stritch School of Medicine, discusses several presentations at ICAAC 2015 that focused on new approaches to the treatment of Clostridium difficile infection and recurrence and the need for more effective C. difficile management strategies.